Objective Coronavirus disease 2019 (COVID-19) is a novel infectious disease caused by
the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Several reports …

Clinical experience on meropenem–clavulanate to treat tuberculosis (TB) is anecdotal (according
to case reports on 10 patients). The aim of our case–control study was to evaluate the …

Background: Salmonellosis remains one of the most frequent food-borne diseases
worldwide, especially in developing countries. The emergence of antimicrobial resistance in …

Background COVID-19 is an infectious disease caused by a novel coronavirus (SARS-CoV-2).
The immunopathogenesis of the infection is currently unknown. Healthcare workers (…

In view of the broad potential biomedical applications of carbon nanotubes (CNTs) different
studies were performed to assess their effect on the immune system. However, the work …

Background: Cytomegalovirus (CMV) infection is the most frequent congenital infection in
humans. Its prevalence and the frequency of disabling sequelae must be assessed in different …

Background. Although combinations of antibiotics and antisecretory drugs are useful for
treatment of Helicobacter pylori infection, treatment failure is common. The aim of this study was …

No large study to date has ever evaluated the effectiveness, safety and tolerability of
imipenem/clavulanate versus meropenem/clavulanate to treat multidrug- and extensively drug-…

Background Human Papillomavirus (HPV) is the most common sexually transmitted infection.
The main risk factors correlated with HPV infection are: early sexual debut, the number of …

Background: The objective evaluation of the olfactory function of coronavirus disease 2019
patients is difficult because of logistical and operator-safety problems. For this reason, in the …